NYSE Euronext (NYX) today announced trading volumes for its
global derivatives and cash equities exchanges for April 20131.
Global derivatives average daily volume (“ADV”) of 7 million
contracts, excluding Bclear in April 2013 increased 4% compared to
April 2012, and decreased 3% from March 2013. U.S. equity options
volumes rebounded in April 2013 with an increase of 10% compared to
April 2012 and an increase of 15% from March 2013 levels. ADV in
U.S. cash equities declined 10% year-over-year, but increased 2%
month-over-month. European cash equities ADV in April 2013
decreased 20% compared to April 2012, but increased 8% from March
2013 levels.
Highlights
- NYSE Euronext global derivatives ADV in
April 2013 of 6.9 million contracts, excluding Bclear increased
3.2% compared to April 2012 and decreased 3.4% from March 2013
levels.
- NYSE Euronext European derivatives
products ADV in April 2013 of 2.6 million contracts, excluding
Bclear, decreased 5.8% compared to April 2012, and decreased 22.3%
from March 2013 levels. Including Bclear, NYSE Liffe’s trade
administration and clearing service for OTC products, European
derivatives ADV decreased 18.2% compared to April 2012 and
decreased 18.0% from March 2013.
- NYSE Euronext U.S. equity options (NYSE
Arca and NYSE Amex) ADV of 4.3 million contracts in April 2013
increased 10.1% compared to April 2012 levels and increased by
14.6% from March 2013 levels. NYSE Euronext’s U.S. options
exchanges accounted for 28.0% of total U.S. consolidated equity
options trading in April 2013, up from 26.4% in April 2013.
- NYSE Liffe U.S. ADV of approximately
47,100 contracts decreased from 61,500 contracts in April 2012 and
decreased from 78,100 contracts in March 2013.
- NYSE Euronext European cash products
ADV of 1.5 million transactions in April 2013 decreased 19.8%
compared to April 2012, but increased 7.5% compared to March
2013.
- NYSE Euronext U.S. cash products (NYSE,
NYSE Arca and NYSE-MKT) handled ADV of 1.6 billion shares in April
2013 a decrease of 9.5% compared to April 2012, but increased 2.3%
compared to March 2013. NYSE Euronext’s Tape A matched market share
in April 2013 was 30.2%, down from 31.3% in April 2012 and down
from 31.1% in March 2013.
__________________________________
1 All NYSE Euronext derivatives transactions count buy and sell
orders together as a single transaction. NYSE Euronext European
equities transactions count each buy and sell order as separate
transactions, NYSE Euronext U.S. equities transactions count buy
and sell orders together as a single transaction.
Please click here for the Monthly Transaction Activity Data
Table.
About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial
markets and provider of innovative trading technologies. The
company's exchanges in Europe and the United States trade equities,
futures, options, fixed-income and exchange-traded products. With
approximately 8,000 listed issues (excluding European Structured
Products), NYSE Euronext's equities markets - the New York Stock
Exchange, NYSE Euronext, NYSE MKT, NYSE Alternext and NYSE Arca -
represent one-third of the world’s equities trading, the most
liquidity of any global exchange group. NYSE Euronext also operates
NYSE Liffe, one of the leading European derivatives businesses and
the world's second-largest derivatives business by value of
trading. The company offers comprehensive commercial technology,
connectivity and market data products and services through NYSE
Technologies. NYSE Euronext is in the S&P 500 index. For more
information, please visit: http://www.nyx.com.
Please follow us at:
Exchanges Blog
Facebook
LinkedIn
Twitter
CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS
This written communication contains “forward-looking statements”
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. In some cases, you can
identify forward-looking statements by words such as “may,” “hope,”
“will,” “should,” “expect,” “plan,” “anticipate,” “intend,”
“believe,” “estimate,” “predict,” “potential,” “continue,” “could,”
“future” or the negative of those terms or other words of similar
meaning. You should carefully read forward-looking statements,
including statements that contain these words, because they discuss
our future expectations or state other “forward-looking”
information. Forward-looking statements are subject to numerous
assumptions, risks and uncertainties which change over time. ICE
Group, ICE and NYSE Euronext caution readers that any
forward-looking statement is not a guarantee of future performance
and that actual results could differ materially from those
contained in the forward-looking statement.
Forward-looking statements include, but are not limited to,
statements about the benefits of the proposed merger involving ICE
Group, ICE and NYSE Euronext, including future financial results,
ICE’s and NYSE Euronext’s plans, objectives, expectations and
intentions, the expected timing of completion of the transaction
and other statements that are not historical facts. Important
factors that could cause actual results to differ materially from
those indicated by such forward-looking statements are set forth in
ICE’s and NYSE Euronext’s filings with the U.S. Securities and
Exchange Commission (the “SEC”). These risks and uncertainties
include, without limitation, the following: the inability to close
the merger in a timely manner; the inability to complete the merger
due to the failure of NYSE Euronext stockholders to adopt the
merger agreement or the failure of ICE stockholders to adopt the
merger agreement or approve related proposals; the failure to
satisfy other conditions to completion of the merger, including
receipt of required regulatory and other approvals; the failure of
the proposed transaction to close for any other reason; the
possibility that any of the anticipated benefits of the proposed
transaction will not be realized; the risk that integration of NYSE
Euronext’s operations with those of ICE will be materially delayed
or will be more costly or difficult than expected; the challenges
of integrating and retaining key employees; the effect of the
announcement of the transaction on ICE’s, NYSE Euronext’s or the
combined company’s respective business relationships, operating
results and business generally; the possibility that the
anticipated synergies and cost savings of the merger will not be
realized, or will not be realized within the expected time period;
the possibility that the merger may be more expensive to complete
than anticipated, including as a result of unexpected factors or
events; diversion of management’s attention from ongoing business
operations and opportunities; general competitive, economic,
political and market conditions and fluctuations; actions taken or
conditions imposed by the United States and foreign governments or
regulatory authorities; and adverse outcomes of pending or
threatened litigation or government investigations. In addition,
you should carefully consider the risks and uncertainties and other
factors that may affect future results of the combined company, as
are described in the section entitled “Risk Factors” in the joint
proxy statement/prospectus filed by ICE Group with the SEC, and as
described in ICE’s and NYSE Euronext’s respective filings with the
SEC that are available on the SEC’s web site located at
www.sec.gov, including the sections entitled “Risk Factors” in
ICE’s Form 10-K for the fiscal year ended December 31, 2012, as
filed with the SEC on February 6, 2013, and “Risk Factors” in NYSE
Euronext’s Form 10-K for the fiscal year ended December 31, 2012,
as filed with the SEC on February 26, 2013. You should not place
undue reliance on forward-looking statements, which speak only as
of the date of this written communication. Except for any
obligations to disclose material information under the Federal
securities laws, ICE Group, ICE and NYSE Euronext undertake no
obligation to publicly update any forward-looking statements to
reflect events or circumstances after the date of this written
communication.
IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND WHERE
TO FIND IT
This communication does not constitute an offer to sell or the
solicitation of an offer to buy any securities or a solicitation of
any vote or approval. In connection with the proposed transaction,
ICE Group has filed with the SEC a registration statement on Form
S−4, which the SEC has declared effective and which contains a
joint proxy statement/prospectus with respect to the proposed
acquisition of NYSE Euronext by ICE Group. The final joint proxy
statement/prospectus will be delivered to the stockholders of ICE
and NYSE Euronext. INVESTORS AND SECURITY HOLDERS OF BOTH ICE AND
NYSE EURONEXT ARE URGED TO READ THE JOINT PROXY
STATEMENT/PROSPECTUS REGARDING THE PROPOSED TRANSACTION CAREFULLY
AND IN ITS ENTIRETY, INCLUDING ANY DOCUMENTS PREVIOUSLY FILED WITH
THE SEC AND INCORPORATED BY REFERENCE INTO THE JOINT PROXY
STATEMENT/PROSPECTUS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO
THOSE DOCUMENTS, BECAUSE IT WILL CONTAIN IMPORTANT INFORMATION
REGARDING ICE, NYSE EURONEXT AND THE PROPOSED TRANSACTION.
Investors and security holders may obtain a free copy of the joint
proxy statement/prospectus, as well as other filings containing
information about ICE and NYSE Euronext, without charge, at the
SEC’s website at http://www.sec.gov. Investors may also obtain
these documents, without charge, from ICE’s website at
http://www.theice.com and from NYSE Euronext’s website at
http://www.nyx.com.
PARTICIPANTS IN THE MERGER SOLICITATION
ICE, NYSE Euronext and their respective directors, executive
officers and other members of management and employees may be
deemed to be participants in the solicitation of proxies in respect
of the transactions contemplated by the Merger Agreement.
You can find information about ICE and ICE’s directors and
executive officers in ICE’s Annual Report on Form 10-K for the year
ended December 31, 2012, as filed with the SEC on February 6, 2013,
and ICE’s proxy statement for its 2012 annual meeting of
stockholders, as filed with the SEC on March 30, 2012.
You can find information about NYSE Euronext and NYSE Euronext’s
directors and executive officers in NYSE Euronext’s Annual Report
on Form 10-K for the year ended December 31, 2012, as filed with
the SEC on February 26, 2013, NYSE Euronext’s proxy statement for
its 2012 annual meeting of stockholders, filed with the SEC on
March 26, 2012.
Additional information about the interests of potential
participants is included in the joint proxy statement/prospectus,
and the other relevant documents filed by ICE and NYSE Euronext
with the SEC.
NYSE
Euronext
Monthly Volume
Summary
Average Daily Volume Total
Volume Average Daily Volume Total
Volume (Unaudited; contracts in thousands)
% Chg
vs. % Chg vs. Apr-13 Apr-12 % Chg
Apr-13 Apr-12 % Chg YTD 2013 YTD
2012 YTD 2013 YTD 2012 Number of Trading
Days - European Cash 21 19 21 19 83 83 Number of Trading Days -
European Derivatives 21 19 21 19 83 83 Number of Trading Days -
U.S. Markets 22 20 22 20 82 82
European Derivatives
Products 3,493 4,270 -18.2 %
73,352 81,127 -9.6 % 4,256
20.1 % 353,288 18.7 % of which
Bclear 856 1,471 -41.8 % 17,981 27,945 -35.7 % 876 2.7 % 72,730 1.5
%
Total Fixed Income Products 1,753
1,792 -2.2 % 36,803 34,049
8.1 % 2,497 40.4 %
207,236 38.7 % Short Term Interest Rate
Products 1,621 1,665 -2.7 % 34,036 31,636 7.6 % 2,322 42.3 %
192,745 40.6 % Medium and Long Term Interest Rate Products 1 132
127 3.7 % 2,768 2,414 14.7 % 175 19.2 % 14,491 17.8 %
Total Equity Products 2 1,637 2,397
-31.7 % 34,379 45,538 -24.5
% 1,665 -1.2 % 138,181
-2.4 % Individual Equity Products 1,142 1,847
-38.1 % 23,986 35,085 -31.6 % 1,135 -5.9 % 94,164 -7.1 % Futures
766 1,325 -42.2 % 16,094 25,173 -36.1 % 687 -1.1 % 57,042 -2.2 %
Options 376 522 -28.0 % 7,892 9,913 -20.4 % 447 -12.6 % 37,122
-13.6 % Equity Index Products 495 550 -10.0 % 10,394 10,453 -0.6 %
530 10.9 % 44,017 9.5 % of which Bclear 856 1,471 -41.8 %
17,971 27,945 -35.7 % 875 2.5 % 72,610 1.3 % Individual Equity
Products 786 1,409 -44.2 % 16,513 26,765 -38.3 % 765 -2.2 % 63,521
-3.4 % Futures 718 1,253 -42.7 % 15,086 23,816 -36.7 % 667 -0.8 %
55,353 -2.0 % Options 68 155 -56.2 % 1,427 2,948 -51.6 % 98 -11.0 %
8,168 -12.0 % Equity Index Products 69 62 11.8 % 1,458 1,180 23.5 %
109 55.6 % 9,088 53.7 %
Commodity Products 103
81 27.5 % 2,169 1,539
40.9 % 95 16.6 % 7,870
15.2 % U.S. Derivatives Products
Equity Options 3
NYSE Euronext Options Contracts 4,298 3,903 10.1 % 94,548
78,050 21.1 % 4,249 4.3 % 348,391 4.3 % Total Consolidated Options
Contracts 15,352 14,772 3.9 % 337,754 295,434 14.3 % 15,081 -3.4 %
1,236,640 -3.4 % NYSE Group Share of Total 28.0 % 26.4 %
28.0 % 26.4 % 28.2 % 2.1 % 28.2 % 2.1 %
NYSE Liffe
U.S. Futures and Futures Options Volume* 47.1 61.5 -23.3
% 1,036 1,291 -19.7 % 55.7 -36.5 % 4,677.5 -37.2 %
European Cash Products (trades in thousands) 1,495
1,865 -19.8 % 31,399 35,444
-11.4 % 1,407 -14.6 %
116,819 -15.6 % Equities 1,444 1,810
-20.2 % 30,314 34,385 -11.8 % 1,356 -14.9 % 112,513 -15.9 %
Exchange-Traded Funds 14 16 -10.0 % 299 301 -0.6 % 14 -6.5 % 1,147
-7.7 % Structured Products 33 35 -5.9 % 684 658 4.0 % 33 -5.5 %
2,703 -6.6 % Bonds 5 5 -8.2 % 102 101 1.5 % 5 12.0 % 455 10.7 %
U.S. Cash Products (shares in millions) 5
1,555 1,719 -9.5 % 34,217
34,378 -0.5 % 1,548 -12.4
% 126,938 -12.4 % NYSE Listed
(Tape A) Issues 4 Handled Volume 5 1,105 1,238
-10.7 % 24,308 24,760 -1.8 % 1,116 -11.8 % 91,515 -11.8 % Matched
Volume 6 1,065 1,170 -9.0 % 23,424 23,408 0.1 % 1,073 -10.1 %
88,027 -10.1 % Total NYSE Listed Consolidated Volume 3,529 3,743
-5.7 % 77,641 74,867 3.7 % 3,570 -8.1 % 292,752 -8.1 %
Share of Total Consolidated Volume Handled Volume 5 31.3 %
33.1 % -1.8 % 31.3 % 33.1 % -1.8 % 31.3 % -1.3 % 31.3 % -1.3 %
Matched Volume 6 30.2 % 31.3 % -1.1 % 30.2 % 31.3 % -1.1 % 30.1 %
-0.7 % 30.1 % -0.7 %
NYSE Arca, MKT and Regional (Tape B)
Listed Issues Handled Volume 5 264 253 4.3 % 5,813 5,067
14.7 % 235 -10.4 % 19,279 -10.4 % Matched Volume 6 243 226 7.4 %
5,351 4,530 18.1 % 217 -7.4 % 17,786 -7.4 % Total NYSE Arca &
MKT Listed Consolidated Volume 1,165 1,094 6.5 % 25,640 21,876 17.2
% 1,040 -6.8 % 85,307 -6.8 %
Share of Total Consolidated
Volume Handled Volume 5 22.7 % 23.2 % -0.5 % 22.7 % 23.2 % -0.5
% 22.6 % -0.9 % 22.6 % -0.9 % Matched Volume 6 20.9 % 20.7 % 0.2 %
20.9 % 20.7 % 0.2 % 20.8 % -0.1 % 20.8 % -0.1 %
Nasdaq
Listed (Tape C) Issues Handled Volume 5 186 228 -18.2 %
4,096 4,552 -10.0 % 197 -17.8 % 16,144 -17.8 % Matched Volume 6 168
192 -12.4 % 3,691 3,832 -3.7 % 176 -13.0 % 14,449 -13.0 % Total
Nasdaq Listed Consolidated Volume 1,689 1,704 -0.9 % 37,155 34,074
9.0 % 1,786 0.7 % 146,471 0.7 %
Share of Total
Consolidated Volume Handled Volume 5 11.0 % 13.4 % -2.4 % 11.0
% 13.4 % -2.4 % 11.0 % -2.5 % 11.0 % -2.5 % Matched Volume 6 9.9 %
11.2 % -1.3 % 9.9 % 11.2 % -1.3 % 9.9 % -1.5 % 9.9 % -1.5 %
Exchange-Traded Products 5,7 Handled Volume 5
252 242 4.1 % 5,548 4,846 14.5 % 223 -9.7 % 18,281 -9.7 % Matched
Volume 6 232 216 7.4 % 5,112 4,327 18.1 % 206 -6.5 % 16,873 -6.5 %
Total ETF Consolidated Volume 1,128 1,074 5.0 % 24,826 21,487 15.5
% 1,005 -7.1 % 82,381 -7.1 %
Share of Total Consolidated
Volume Handled Volume 5 22.3 % 22.6 % -0.3 % 22.3 % 22.6 % -0.3
% 22.2 % -0.6 % 22.2 % -0.6 % Matched Volume 6 20.6 % 20.1 % 0.5 %
20.6 % 20.1 % 0.5 % 20.5 % 0.2 % 20.5 % 0.2 %
1
Data includes currency products.
2
Includes all trading activities for
Bclear, NYSE Liffe's clearing service for wholesale
derivatives.
3
Includes trading in U.S. equity options
contracts, not equity-index options.
4
Includes all volume executed in NYSE Group
crossing sessions.
5
Represents the total number of shares of
equity securities and ETFs internally matched on the NYSE Group's
exchanges or routed to and executed at an external market center.
NYSE Arca routing includes odd-lots.
6
Represents the total number of shares of
equity securities and ETFs executed on the NYSE Group's
exchanges.
7
Data included in previously identified
categories.
*
ADVs calculated with the appropriate
number of NYSE Liffe U.S. trading days.
Source: NYSE Euronext, Options Clearing Corporation and
Consolidated Tape as reported for equity securities. All trading
activity is single-counted, except European cash trading which is
double counted to include both buys and sells.
Grafico Azioni NYSE Group (NYSE:NYX)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni NYSE Group (NYSE:NYX)
Storico
Da Lug 2023 a Lug 2024